Sinopharm Group Co Ltd

Sinopharm Group Co Ltd, founded in 2003, has established itself as a prominent entity with its headquarters in Shanghai, China. The company has diversified its operations into key segments such as Pharmaceutical Distribution, which deals with medicines and medical devices; Retail Pharmacy, which consists of a network of pharmacies throughout China; Medical Devices, focusing on the distribution and manufacturing of medical equipment and instruments; and BioPharmaceutical, where the emphasis is on research, development, and manufacturing of biopharmaceutical products. Prominent brands under Sinopharm Group include Sinopharm Accord, which offers various medical products and healthcare solutions, and Sinovac, through its subsidiary Sinovac Biotech, which gained worldwide recognition for the CoronaVac COVID-19 vaccine. Another significant subsidiary is Beijing Tiantan Biological Products, specializing in vaccine manufacturing. While Sinopharm's presence is strongly felt in the Chinese market, the company has extended its services and product distribution to numerous countries around the world, concentrating on areas such as Africa, the Middle East, Asia, and Latin America. This international presence is fostered through an array of partnerships, subsidiaries, and exports, emphasizing Sinopharm's global footprint. (Powered by AI)